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Background: Bovine cutaneous fibropapillomas are benign hyperproliferative lesions induced by Bovine
Papillomaviruses (BPVs). Bcl-2 is an important anti-apoptotic protein which is expressed in several cancer types. In
contrary, p53 is a tumour suppressor protein that mediates cell cycle arrest, apoptosis and senescence in response
to cellular stresses.
Findings: Here, we investigated immunohistochemically and biochemically, the expression of bcl-2 and p53 in a
subset of BPV positive fibropapillomas and bovine normal skin. Normal skin samples showed a weak signal for both
proteins in the cytoplasm of the basal cells. Nine out of twelve (75%) tumour samples stained positive for bcl-2
throughout basal and parabasal layers, with most of cells showing strong cytoplasmic immunoreactivity. Nine out
of twelve (75%) fibropapillomas were found to be positive for p53 expression, showing a strong cytoplasmic and
perinuclear staining of p53 protein mainly in the basal and parabasal layers.
Conclusions: Our data reveal an altered bcl-2 and p53 immunoreactivity in bovine cutaneous fibropapillomas,
suggesting involvement of these two proteins in the cutaneous neoplastic transformation through an impaired
apoptotic process.
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Bovine cutaneous fibropapillomas are benign hyperproli-
ferative lesions induced by different BPVs types, infect-
ing both the epithelial cells and the underlying dermis
[1]. These lesions usually undergo spontaneous regres-
sion, although in some cases the bovines might develop
extensive papillomas resulting in debilitated animals that
may succumb [1].
BPV infection is supposed to be the most important
causal factor in fibropapilloma development and our
previous studies on these tumours have demonstrated
alterations of GAP junction proteins and signaling trans-
duction pathways [2]. However, the mechanisms under-
lying cutaneous fibropapilloma development are not yet
fully understood.
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unless otherwise stated.as in several animal species. These viruses have developed
numerous strategies in order to block host-mediated
apoptosis, contributing to cancer development [3].
Programmed cell death, known as apoptosis, is a pivotal
mechanism of cell death that plays an important role dur-
ing diverse biological processes, including development,
cell differentiation and proliferation [4]. The regulation of
cells undergoing apoptosis is controlled by the bcl-2 pro-
teins family; it includes both pro- (i.e. Bax, Bak) and anti-
apoptotic proteins (i.e. bcl-2 itself ) triggering or blocking,
respectively, the release from mythocondria of proteins ac-
tivating the apoptotic molecular cascade [4]. Generally,
cells at proliferative stages express bcl-2, whilst it is down-
regulated in cells undergoing differentiation; indeed, bcl-2
is expressed in the germinal layer of epithelium, indicating
a role in protecting the cells from apoptosis and providing
a perpetual supply of cells for differentiation [5]. Several
mechanisms have been found to cause bcl-2 dysregulation
and cancer, including activating chromosomal translocation
[6] and up-regulation upon viral infection: for instance, up-
regulated bcl-2 expression has been described in different
tumours, including premalignant and malignant lesions ofal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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(HPVs) [7-9]. In veterinary oncology, impaired bcl-2 ex-
pression has been recorded also in different feline epithe-
lial tumours, such as basal cell tumour, carcinoma in situ
and mammary carcinoma [10].
P53 is a tumour suppressor protein that mediates cell
cycle arrest, DNA integrity and repairing, apoptosis
and senescence in response to specific cellular stresses
(e.g. various types of DNA damage, hypoxia, oncogene
deregulation, oxidative damage) [11]. As a consequence of
stress, p53 translocates from the nucleus to the cell cyto-
plasm where it directly interacts with and regulates mem-
bers of the bcl-2 proteins family, including bcl-2 itself.
This results in the release of various pro-apoptotic pro-
teins, which in turn activate apoptosis [11].
P53 has a significant role in cell cycle control, therefore
the loss of its suppressive function has been reported
for different types of human neoplasia and animal tu-
mours, such as BPV induced tumours [12-14]. However,
studies concerning the expression and the impact of
anti-apoptotic protein bcl-2 and the tumour suppressor
p53 in BPV induced cutaneous tumours are lacking.
Findings
In this study, we investigated the expression of p53 and
bcl-2 in bovine fibropapillomas according to the detailed
“Materials and Methods” in the Additional file 1. Histo-
pathologically, the tumours were all classified as cutane-
ous fibropapillomas. The PCR assay confirmed the
presence of the BPV −1/-2 DNA in the tested samples,Table 1 BPV 1/2 DNA presence and bcl-2 and p53 protein exp
fibropapillomas
Sample BPV 1/2 DNA Bcl-2
Staining Pattern
T1 + Yes Cytoplasmic, Membranous
T2 + Yes Cytoplasmic, Membranous
T3 + Yes Cytoplasmic, Membranous
T4 + Yes Cytoplasmic, Membranous
T5 + Yes Cytoplasmic, Membranous
T6 + No No
T7 + Yes Cytoplasmic
T8 + Yes Cytoplasmic, Membranous
T9 + No No
T10 + Yes Cytoplasmic, Membranous
T11 + No No
T12 + Yes Cytoplasmic
N1 + Yes Cytoplasmic
N2 + Yes Cytoplasmic
The presence of BPV 1/2 DNA is indicated by “+”. The cellular pattern of the immun
perinuclear. The intensity of immunolabelling for each specimen was scored in a “b
++, moderate signal; +++, strong signal. “T” stands for tumour samples and “N” stanas detailed in Table 1. The expression of bcl-2 and p53
was assessed by immunohistochemistry and Western
blot. Nine out of twelve (75%) fibropapillomas samples
stained positive for bcl-2 throughout basal and parabasal
layers, with most of cells showing strong cytoplasmic
and membrane immunoreactivity (Figure 1A). The nor-
mal skin samples showed weak bcl-2 cytoplasmic stain-
ing, which was confined to the cells of basal layer
(Figure 1B). The intensity and the expression pattern of
each sample are summarized in Table 1. A human non-
Hodgkin lymphoma used as positive control exhibited a
strong cytoplasmic immunoreactivity (Figure 1C). Fur-
ther, to check whether the expression of bcl-2 influences
the rate of cell survival, we determined the apoptotic
index (AI) comparing bcl-2 positive versus bcl-2 nega-
tive samples, as described in “Materials and Methods”
section in Additional file 1. An AI of 43% (±5.2) was
observed in bcl-2 negative fibropapillomas, whereas bcl-
2 positive samples showed an AI of 37% (±2.57) (data
not shown).
Nine out of the 12 (75%) bovine fibropapillomas were
found to be positive for p53 expression. In most samples,
a strong expression of p53 protein was detected in the
basal layer and parabasal layer, where cells with a cytoplas-
mic and perinuclear staining were recorded (Figure 2A).
In the spinous and granular layers, few cells with an in-
tense perinuclear staining were observed. In normal skin
samples, the expression of p53 was weak and limited to
the cytoplasm of the cells of basal layer (Figure 2B). The
positive control represented by human mammary cancerression in normal skin and bovine cutaneous
p53
Intensity Staining Pattern Intensity
+++ Yes CytoplasmicPerinuclear ++
+++ Yes CytoplasmicPerinuclear +++
++ Yes CytoplasmicPerinuclear ++
++ Yes CytoplasmicPerinuclear +++
+++ Yes CytoplasmicPerinuclear +
- Yes CytoplasmicPerinuclear +
+++ Yes Cytoplasmic +
++ No NoNo -
- No NoNo -
+ Yes CytoplasmicPerinuclear ++
- No No -
++ Yes CytoplasmicPerinuclear +++
+ Yes Cytoplasmic +
+ Yes CytoplasmicPerinuclear ++
oreactivity is either indicated with cytoplasmic and/or membranous and/or
lind study” on a four-tiered scale: −, absent; +, weak signal or very weak signal;
ds for normal skin samples.
Figure 1 Bcl-2 expression in bovine cutaneous fibropapillomas and normal skin; (A) bcl-2 is strongly expressed in the cytoplasm and
membrane of the neoplastic cells of the basal and parabasal layers (white arrowhead); (B) Normal skin sample showing a weak expression
of bcl-2 limited to the cytoplasm of the cells of basal layer (black arrowhead); (C) A positive control represented by human non- Hodgkin
lymphoma showed a cytoplasmic immunoreactivity. IHC X 200.
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specificity of the antibodies used throughout the study,
Western blot analysis was performed, showing a band of
the expected size for bcl-2 (25KDa) and p53 (53KDa) in
the tested samples as well as in HEK293 cell line used as
positive control (Figure 3A, 3B).
By immunohistochemistry, two fibropapilloma samples
(T9 and T11) did not expressed neither bcl-2 nor p53
proteins. The lack of reactivity might be due to the loss of
antigenicity.
Bovine cutaneous fibropapillomas are benign lesions
known to affect cattle worldwide. BPV are considered as
causative agents of these tumours, inducing the prolifera-
tion of both epithelial and dermal cells [1]. Apoptosis is a
tightly regulated process that plays an important role in
development and homeostasis, responsible for the balance
between cell proliferation and cell death, where bcl-2 has
been proven to have a central role [6].The deregulation
of the normal apoptotic process is considered as an
“hallmark” of cancer [5,7,15,16]. In our study we showed
that in normal skin bcl-2 protein expression is confined to
the cytoplasm of the basal cell layer, which is in agreement
to that described in feline, canine and human skin [10,17].
The basal keratinocyte-restricted expression of bcl-2suggests that it may protect the cells from apoptosis, being
responsible for the proliferation and regeneration of the
epithelium [5]. Bcl-2 expression in the cytoplasm and
plasma membrane specifically inhibits the cell death,
resulting in cell surviving [18]. In BPV positive fibropapil-
lomas, a strong immunoreactivity of bcl-2 was observed
in all layers. This is the first time, to the best of our
knowledge that bcl-2 is reported to be expressed in the
membrane and the cytoplasm of bovine neoplastic cells,
suggesting an active pathogenic contribution in protecting
these cells by inhibiting the normal apoptotic processes.
Similarly, a relatively high bcl-2 expression was recorded
in HPV associated epidermodysplasia verruciformis, where
the interaction between oncogenic HPV and bcl-2 may
result in increased susceptibility toward acquirement of
somatic mutations and malignant transformation [16].
We speculate that bcl-2 deregulation maybe a common
mechanism in PVs induced cancerogenesis.
In our study, bcl-2 positive samples showed a reduced
number of TUNEL positive cells when compared to the
bcl-2 negative fibropapillomas. This is in accordance with
human counterpart, where in head and neck squamous
cell carcinomas the number of apoptotic cells was noted
to be reduced in bcl-2 positive tumours when compared
Figure 2 P53 expression in bovine cutaneous fibropapillomas and normal skin; (A) p53 is expressed in the cytoplasm of basal (white
arrowhead) and parabasal epithelial cells; note a perinuclear pattern in some cells of the parabasal layer (black arrowhead); (B) Normal
skin samples showing a weak p53 cytoplasmic staining, confined to the basal cell layer (white arrow); (C) Epithelial cells of human
mammary cancer showed cytoplasmic immunoreactivity (black arrow). IHC, A X 400, B, C X 200.
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apoptosis might be regulated by bcl-2 expression also in
BPV induced fibropapillomas. Bcl-2 upregulation is one of
the potential mechanisms by which tumour cells escape
from p53 mediated apoptosis; functional p53 inhibits bcl-2
expression and its anti-apoptotic function, thus altered
localization and/or expression of p53 may lead to bcl-2
overexpression and exertion of its anti-apoptotic activity [8].Figure 3 Western blotting for bcl-2 and p53 proteins in bovine
cutaneous fibropapillomas and normal skin. (A) Western blot
analysis of bcl-2 in bovine normal skin and fibropapillomas (upper blot);
the blot was stripped and reprobed with anti-β-actin antibody to
confirm equal loading of proteins in each lane (lower blot). (B) Western
blot analysis of p53 in bovine normal skin and fibropapillomas (upper
blot); the blot was stripped and reprobed with anti-β-actin antibody to
confirm equal loading of proteins in each lane (lower blot).Normally, a very low expression of p53 protein is
detected in cells; in response to cellular stresses, however,
the protein is stabilized and cell division is inhibited in
order to respond to such damage [19].
Our results indicate that p53 is weakly expressed in
basal epithelial cells of normal skin samples. Accordingly,
a similar p53 expression pattern in the basal epithelial
cells has been recorded in human normal skin, suggesting
that it may exert its physiological function in bovine
healthy epithelium [15,20,21].
Fibropapilloma samples showed a strong cytoplasmic
and perinuclear p53 expression in the basal and parabasal
cell layers. Cytoplasmic accumulation of p53 has been
proposed as a considerable mechanism to disrupt its
function as a tumour suppressor and its expression has
been reported in different human and animal tumours
[22,23]. Recent findings report cytoplasmic overexpression
of p53 in BPV induced equine sarcoids; moreover, a
perinuclear p53 expression has been reported in the same
tumours, suggesting that p53 alteration contributes to
disruption of the equilibrium of cell growth and cell death
in BPV associated tumours in different species [12,13,24].
However, the higher expression of p53 in epithelial
component of fibropapilloma may be due to different
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p53 protein or accumulation of mutated p53, resulting in
a permanent abnormal form of p53 that is not functional
and/or resistant to degradation [25].
Our results indicate that bcl-2 expression may promote
the survival of the neoplastic cells possibly depending on
p53 impaired expression.
Despite a number of studies have higlighted a role for
BPV’s oncogenes in impairing some cellular pathways and
leading to neoplastic transformation, nothing is known
about a possible interplay among the viral oncoproteins
and bcl-2 and p53 dysregulation. Thus, the unraveling of
new pathways possibly involved in the pathogenesis of
bovine cutaneous fibropapillomas is of a great importance
to complete the molecular scenario triggering to the
development of these tumours.
In summary, the current study provides evidence for
p53 and bcl-2 expression in a majority of BPV-induced
bovine tumours, suggesting an involvement of these two
proteins in bovine cutaneous fibropapilloma development.
Further studies are needed to better understand bcl-2 and
p53 function in vivo carcinogenesis.
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